<p>Lung (A) or spleen (B) bacterial burdens of C57BL/6 mice infected with <i>M</i>. <i>tuberculosis</i> H37Rv via aerosol administration. Mice were vaccinated s.c. four weeks before the challenge, with 1 x 10<sup>6</sup> CFU/mouse of either BCG or BCG38 (indicated in green). Both strains were prepared, either in standard culture conditions in medium containing 0.025% Tween-80 considered as no capsule (indicated with (-)), or in culture allowing capsule formation/retention in detergent free condition (indicated with (+)). Photographs of the assessed organs are depicted in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1007139#ppat.1007139.s002" target="_blank">S2A and S2B Fig</a>. Each data point represents the C...
<p>Five mice per group were vaccinated with i) 10<sup><b>6</b></sup> CFU BCG, ii) 10<sup><b>6</b></s...
<p>A) BCG priming and boosting protocol with PE/PPE-derived peptides. C57BL/6 mice (<i>n</i> = 6 per...
<p>Mice were immunized subcutaneously with two different doses (10 μg and 2 μg) of LT69 formulated i...
<p>A) Graphical representation of the prime-boost vaccination protocol. Mice were immunized with eit...
A) Groups of five C57 mice were intradermally vaccinated with 105 CFU of BCG (BCG), heat-killed BCG ...
Background: The only available tuberculosis (TB) vaccine, Bacillus Calmette-Guérin (BCG), has variab...
<p>Infant and adult mice were BCG immunized, and boosted with AdHu5Ag85A i.n. at 16 weeks post-BCG (...
<p>Mice were primed with BCG and boosted by EAMM/AMM two times at the 12th and 14th week. Ten weeks ...
The global epidemic caused by the bacterial pathogen Mycobacterium tuberculosis continues unabated. ...
<p>Ninety days after immunization, three mice from each group (control, BCG and rBCG-CMX) were chall...
ABSTRACT Many studies of Mycobacterium tuberculosis infection and immunity have used mouse models. H...
Despite issues relating to variable efficacy in the past, the Mycobacterium bovis BCG vaccine remain...
<p>Mice were challenged with <i>M. tuberculosis</i> 8 weeks after a single s.c. immunization and the...
<p>Mice were immunized and aerosol challenged as mentioned in Figure 1. Mycobacterial load in the lu...
<p>Mice were infected 12 weeks after primary immunization and euthanized at 2, 4 and 10 weeks post-i...
<p>Five mice per group were vaccinated with i) 10<sup><b>6</b></sup> CFU BCG, ii) 10<sup><b>6</b></s...
<p>A) BCG priming and boosting protocol with PE/PPE-derived peptides. C57BL/6 mice (<i>n</i> = 6 per...
<p>Mice were immunized subcutaneously with two different doses (10 μg and 2 μg) of LT69 formulated i...
<p>A) Graphical representation of the prime-boost vaccination protocol. Mice were immunized with eit...
A) Groups of five C57 mice were intradermally vaccinated with 105 CFU of BCG (BCG), heat-killed BCG ...
Background: The only available tuberculosis (TB) vaccine, Bacillus Calmette-Guérin (BCG), has variab...
<p>Infant and adult mice were BCG immunized, and boosted with AdHu5Ag85A i.n. at 16 weeks post-BCG (...
<p>Mice were primed with BCG and boosted by EAMM/AMM two times at the 12th and 14th week. Ten weeks ...
The global epidemic caused by the bacterial pathogen Mycobacterium tuberculosis continues unabated. ...
<p>Ninety days after immunization, three mice from each group (control, BCG and rBCG-CMX) were chall...
ABSTRACT Many studies of Mycobacterium tuberculosis infection and immunity have used mouse models. H...
Despite issues relating to variable efficacy in the past, the Mycobacterium bovis BCG vaccine remain...
<p>Mice were challenged with <i>M. tuberculosis</i> 8 weeks after a single s.c. immunization and the...
<p>Mice were immunized and aerosol challenged as mentioned in Figure 1. Mycobacterial load in the lu...
<p>Mice were infected 12 weeks after primary immunization and euthanized at 2, 4 and 10 weeks post-i...
<p>Five mice per group were vaccinated with i) 10<sup><b>6</b></sup> CFU BCG, ii) 10<sup><b>6</b></s...
<p>A) BCG priming and boosting protocol with PE/PPE-derived peptides. C57BL/6 mice (<i>n</i> = 6 per...
<p>Mice were immunized subcutaneously with two different doses (10 μg and 2 μg) of LT69 formulated i...